PT97912A - Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT97912A
PT97912A PT97912A PT9791291A PT97912A PT 97912 A PT97912 A PT 97912A PT 97912 A PT97912 A PT 97912A PT 9791291 A PT9791291 A PT 9791291A PT 97912 A PT97912 A PT 97912A
Authority
PT
Portugal
Prior art keywords
aliphatic
compound
aryl
alkyl
process according
Prior art date
Application number
PT97912A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert A Daines
William Dennis Kingsbury
Israil Nmi Pendrak
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PT97912A publication Critical patent/PT97912A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT97912A 1990-06-07 1991-06-07 Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem PT97912A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
PT97912A true PT97912A (pt) 1992-03-31

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97912A PT97912A (pt) 1990-06-07 1991-06-07 Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem

Country Status (16)

Country Link
EP (1) EP0532550A1 (fi)
JP (1) JPH05507475A (fi)
KR (1) KR930700445A (fi)
CN (1) CN1058016A (fi)
AU (1) AU7901791A (fi)
CA (1) CA2083958A1 (fi)
FI (1) FI925544A (fi)
HU (1) HUT64748A (fi)
IE (2) IE911913A1 (fi)
IL (1) IL98388A0 (fi)
MA (1) MA22196A1 (fi)
MX (1) MX26142A (fi)
PL (1) PL290586A1 (fi)
PT (1) PT97912A (fi)
WO (1) WO1991018880A1 (fi)
ZA (1) ZA914323B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4226493A (en) * 1992-05-01 1993-11-29 Smithkline Beecham Corporation Leukotriene antagonists
WO1995015950A1 (en) * 1993-12-08 1995-06-15 Smithkline Beecham Corporation Compounds
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
WO1994014442A1 (en) * 1992-12-23 1994-07-07 Smithkline Beecham Corporation Substituted pyridyl compounds useful as leukotriene antagonists
BR9507459A (pt) * 1994-04-13 1997-11-11 Hoffmann La Roche Antagonistas á base de piridino-leucotrieno b4 substituído
US7297357B2 (en) * 2001-03-27 2007-11-20 Meiji Seika Kaisha, Ltd. Process for producing puffed snack and production apparatus therefor
ES2622522T3 (es) 2003-08-26 2017-07-06 The Regents Of The University Of Colorado, A Body Corporate Inhibidores de la actividad proteasa de serina y su uso en métodos y composiciones para el tratamiento de infecciones bacterianas
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
EP0532550A1 (en) 1993-03-24
FI925544A0 (fi) 1992-12-07
HUT64748A (en) 1994-02-28
CA2083958A1 (en) 1991-12-08
JPH05507475A (ja) 1993-10-28
AU7901791A (en) 1991-12-31
MA22196A1 (fr) 1992-04-01
ZA914323B (en) 1992-06-24
IE911912A1 (en) 1991-12-18
IE911913A1 (en) 1991-12-18
HU9203866D0 (en) 1993-03-29
FI925544A (fi) 1992-12-07
MX26142A (es) 1994-02-28
WO1991018880A1 (en) 1991-12-12
CN1058016A (zh) 1992-01-22
IL98388A0 (en) 1992-07-15
PL290586A1 (en) 1992-04-06
KR930700445A (ko) 1993-03-15

Similar Documents

Publication Publication Date Title
US4711903A (en) Phenolic thioethers as inhibitors of 5-lipoxygenase
JPS63246372A (ja) 3−ヘテロ置換−n−ベンジル−インドール
CN101160285A (zh) 适用于治疗疼痛的n-(n-磺酰氨基甲基)环丙烷甲酰胺衍生物
JP2006528218A (ja) Gfatインヒビター
PT97912A (pt) Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem
JPH0733371B2 (ja) 新規複素環アミド化合物、およびそれらを含有する医薬組成物
PT97913A (pt) Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem
US4694018A (en) Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
JPH0597839A (ja) ホスホリパーゼa2阻害剤としてのテトロン酸誘導体およびチオテトロン酸誘導体
US4663333A (en) Acylaminoalkylpyridines ad use in treatment of inflammation and allergy reactions
PT97911A (pt) Processo de preparacao de derivados de acidos piridilbenzoicos ligados a amida e de composicoes farmaceuticas
JPH0649677B2 (ja) テトラヒドロナフタレン誘導体、その製法並びにその合成中間体
CN100384824C (zh) 乙酰基2-羟基-1,3-二氨基烷烃
JPS61502468A (ja) N−置換ブチルアミド誘導体
US5656636A (en) Pyridine compounds for treating leukotriene-related diseases
EP0532634A1 (en) Phthalamic acids and their isomers for treating leukotriene-related diseases
PT98974A (pt) Processo de preparacao de derivados de acidos piridiltio ou piridiloxi-alcanoicos e de composicoes farmaceuticas que os contem
JP2840337B2 (ja) 腫瘍転移抑制剤
DE19823722A1 (de) Chinolinylmethoxyaryl-Verbindungen als duale Inhibitoren der Cyclooxygenase und 5-Lipoxygenase
US5066679A (en) Phenolic thioalkylamides as inhibitors of 5-lipoxygenase
JP2000501741A (ja) Pde▲iv▼阻害剤としてのジフェニルピリジルエタン誘導体
JPH09506367A (ja) 化合物
JP2004520335A5 (fi)
KR20030066797A (ko) 흥분성 아미노산 수용체 길항제
JPH08505148A (ja) ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911115

FC3A Refusal

Effective date: 19980722